Previous 10 | Next 10 |
The following slide deck was published by TELA Bio, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: TELA Bio, Inc. 2022 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q1 2022 Earnings Call May 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q1 2022 Earnings Call Transcript
TELA Bio press release (NASDAQ:TELA): Q1 GAAP EPS of -$0.75 misses by $0.14. Revenue of $8.23M (+39.5% Y/Y) beats by $0.28M. For further details see: TELA Bio GAAP EPS of -$0.75 misses by $0.14, revenue of $8.23M beats by $0.28M
MALVERN, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own an...
MALVERN, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s...
MALVERN, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own ...
MALVERN, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...
TELA Bio, Inc. (TELA) Q4 2021 Earnings Conference Call March 21, 2022 16:30 ET Company Participants Louisa Smith - Investor Relations Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Drew Staff...
Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q4 2021 Earnings Call Mar 21, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q4 2021 Earnings Call Transcript
TELA Bio press release (NASDAQ:TELA): Q4 GAAP EPS of -$0.59 misses by $0.07. Revenue of $8.37M (+47.6% Y/Y) beats by $0.4M. For further details see: TELA Bio GAAP EPS of -$0.59 misses by $0.07, revenue of $8.37M beats by $0.4M
News, Short Squeeze, Breakout and More Instantly...
MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44 th Annual Growth Con...
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2024 financial results on Mon...
2024-06-27 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...